Lipid management for the primary and secondary prevention of CVD prevention of Flashcards

1
Q

some essential biological functions of lipids

A

they are a precursor of vitamin D

Steroid hormone precursor

they are used in bile acid synthesis

is a plasma lipoprotein constituent

they aid with membrane fluidity

they insulate nerve fibres

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

the main classifications of lipoproteins

A

HDL
LDL
IDL(intermediate density lipoprotein)
VLDL
chylomicron and chylomicron remnant

HDLs are the smallest, and the order follows on as listed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

out of the classifications of liproteins, which have the largest portions of the following molecules;
proteins
cholesterol
triglycerides

A

HDLs
LDLs
Chylomicrons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is a healthy cholesterol level

think anout HDL, LDL and total serum cholesterol levels

A

total serum cholesterol should be below 193mg/dL or 5.0mmol/L

LDL cholesterol should be below 116mg/dL or 3.0mmol

HDL cholesterol levels should be above 1.0mmol/L for a man or 1.2mmol/L for a woman/ above 39mg/dL for a man or 46mg/dL for a woman

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

total cholesterol levels and HDL levels are very sensitive to fasting, true or false

A

false, they are not. therefore they can be used as screening method for CV risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

which lipoprotein classes are recommended for testing while fasting

A

LDLs and triglycerides as they are more affected by fasting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

high levels of TG are associated with low levels of ??

A

triglycerides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

LDL function

A

LDL release cholesterol into the tissues, including the vessel walls.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what does elevated serum LDL cholesterol indicate?

A

it is a predictor of
cardiovascular disease (CVD) events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HDL function

A

HDL brings cholesterol back from the tissues(like blood vessels) to the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is low serum HDL levels(<1mmol/L) a strong predictor of

A

a strong predictor of
coronary heart disease (CHD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how does the size of LDLs affect the CHD risk it poses

A

smaller LDLs pose a higher CV risk than larger LDLs. this is because, Small LDL particles are more easily oxidized, making them more likely to trigger inflammation and plaque formation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Benecheck description

it is the device used commonly in SELFCheck total cholesterol

A

Benecheck is a brand of medical devices that can test blood glucose, cholesterol, uric acid, and more

watch the youtube video on how it works for lipid/ cholesterol testing. the link to the vid can be found on the slides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

some non-pharmacological ways to manage or control high cholesterol levels

A

Eating a heart-healthy diet

weight management

regular exercise

quitting smoking

plant stanols and sterols

alcohol consumption

etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe metabolic syndromes

name 5 markers used in MS diagnosis(at least 3 of these required to make a diagnosis )

A

triglycerides >150mg/dl

HDL(good fats)<40mg/dl in men and <50mg/dl in women

waist circumference >= 40 in men or >=35 in women

high blood pressure

high fasting glucose >=100mg/dl

Plant sterols and stanols are naturally occurring compounds in plants that can help lower cholesterol levels by reducing the absorption of cholesterol in the gut. They have a similar structure to cholesterol, allowing them to compete for absorption in the digestive system, thus preventing some cholesterol from being absorbed into the bloodstream.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

name some classes of drugs or just drugs used in the treatment of high serum lipid levels (hyperlipidaemia)

A

Statins – HMGCoA Inhibition – upregulated LDL receptors

  • Ezetimibe – decrease cholesterol absorption (NPC1L1 block)
  • Fibrates – decrease TAG/fatty acids (PPAR inhibition)
  • Bile acid sequestrants – bind bile acids decreasing enterohepatic recirculation
  • Bempedoic acid – decreases cholesterol synthesis (ACL inhibition)
  • Inclisiran - small interfering RNA which limits production of PCSK9, increasing uptake of LDL-cholesterol and thereby lowering
    levels in blood
17
Q

before initiating treatment for hyperlipidaemia, what initial considerations should be made regarding treatment

A

● Measure non-fasting full lipid profile (total cholesterol, HDL-C, non-HDL-C, triglycerides) and HbA1c as part of an initial baseline assessment.

● Consider secondary causes of hyperlipidaemia and manage as needed.

●Ensure appropriate baseline and follow up tests. Measure BMI.

● Identify and exclude people with contraindications/drug interactions

18
Q

what is the first line non pharmacological treatment for both secondary and primary prevention of CVD in hyperlipidaemia

A

Identify and address all modifiable risk factors - smoking, diet, obesity, alcohol intake, physical activity, blood pressure and HbA1c

19
Q

first line pharmacological treatment for the primary prevention of CVD in hyperlipidaemia, if lifestyle modification is ineffective or inappropriate

A

offer atorvastatin once 20mg daily

then review full lipid profile after 3 months

20
Q

state the conditions that should be met before statin therapy is considered for adults without established CVD in hyperlipidaemia

A
  • if Age ≤84 & QRISK ≥10% over next 10 years
  • if Type 2 diabetes & QRISK ≥10% over next 10 years
  • Type 1 diabetes, if they have one
    or more of the following:
  • Over 40 years
  • Had diabetes for >10 years
  • Have established nephropathy
  • Have other CVD risk factors

*if CKD and eGFR < 60 mL/min/1.73m2 and/or albuminuria

*Age ≥85 years

21
Q

high intensity lipid treatment in hyperlipidaemia should achieve reduction of f non-HDL-C greater than what?

A

40%

Non-HDL cholesterol is a calculated value that represents all the cholesterol in your blood that is not carried by HDL (good) cholesterol. It’s essentially the total cholesterol minus the HDL cholesterol

22
Q

If patients on a high‑intensity statin have side effects, what do we do

A

If patients on a high‑intensity statin have side effects, offer a lower dose or an alternative statin

23
Q

if patients on atorvastatin 20mg still have a higher risk of CVD after 3 months of use, then what do we do for the primary prevention of a cardiovascular event

A

consider increasing the dose every 2-3 months up to a maximum dose of atorvastatin 80mg daily

24
Q

If maximum tolerated dose of statin does not achieve non-HDL-C reduction > 40% of baseline
value after 3 months, what do we do

A

If maximum tolerated dose of statin does not achieve non-HDL-C reduction > 40% of baseline
value after 3 months consider adding Ezetimibe 10mg daily

25
Q

if statin treatment is contraindicated, or not tolerated, what do we do

A

-see AAC statin intolerance algorithm

  • Ezetimibe 10mg monotherapy may be considered. Assess response after 3 months.
    • Ezetimibe 10mg/bempedoic acid 180 mg combination may be considered when ezetimibe alone does not control non-HDL-C/LDL-C well enough
26
Q

do we offer a fibrate, nicotinic acid, bile acid binder or
omega-3 fatty acids alone or in combination with statin, for the prevention of CVD

27
Q

do we give statin treatment straightaway in the secondary prevention of CVD in hyperlipidaemia

28
Q

first line for the secondary prevention of CVD in hyperlipidaemia

A

atorvastatin 80mg once daily

if CKD offer 20mg

review of lipid profile after 3 months

29
Q

WHEN ARE WE TO SUSPECT FAMILIAL HYPERLIPIDAEMIA, AND DO WE USE THE QRISK ASSESSMENT TOOL

A

If TC>7.5mmol/L and/or LDL-C
>4.9mmol/L and/or non-HDL-C
>5.9mmol/L, a personal and/or family
history of confirmed CHD (<60 years)
and with no secondary causes:
suspect familial hypercholesterolaemia
(possible heterozygous FH)

NO WE DONT

30
Q

TREATMENT TARGET FOR FAMILIAL HYPERLIPIDAEMIA

A

If clinical diagnosis of FH and/or other risk factors present** follow the recommended treatment management pathway for primary or secondary
prevention as for non-FH**, BUT
Aim to achieve at least a 50% reduction of LDL-C (or non-fasting non-HDL-C) from baseline.

31
Q

WHAT DO WE USE TO MAKE A CLINICAL DIAGNOSIS OF FH

A

Use the Simon Broome or Dutch Lipid Clinic Network (DLCN) criteria to make a clinical diagnosis of FH.

32
Q

WHEN DO WE USUALLY REFER IN FH

A

they are assessed to be at very high
risk of a coronary event**
- OR therapy is not tolerated
- OR LDL-C remains >5mmol/L
(primary prevention)
- OR LDL-C remains >3.5mmol/L
(secondary prevention)
despite maximal tolerated statin and
ezetimibe therapy.
**defined as any of the following:
* Established coronary heart disease
* Two or more other CVD risk factors

33
Q

SOME EXAMPLES OF INJECTABLE THERAPIES USED IN THE SECONDARY PREVENTION OF CVD

NOTE THEY ARE NOT ONLY USED IN SECONDARY PREVENTION, THEY CAN ALSO BE USED IN PRIMARY PREVENTION BUT NOT AS OFTEN

A

Inclisiran

PCSK9i

THEY ARE USED IN VERY SEVERE CASES WHERE OTHER THERAPIES ARE INEFFECTIVE